Author

Alfredo Caturano

h-index 4 View on Semantic Scholar

We have 5 of 21 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Targeting Lipoprotein(a) in Cardiovascular Disease: Emerging Therapies and Clinical Implications.

Lipoprotein(a) [Lp(a)] is a genetically determined apolipoprotein B-containing lipoprotein independently associated with atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve stenosis (CAVS). Circulating Lp(a) concentrations are largely inherited, minimally responsive to lifestyle modification, and n...

C. Acierno, D. D'Ardes, A. Boccatonda et al. · Journal of Cardiovascular Ph... · 0 citations

Review Open access Sep 2026

From Adipose Tissue Dysfunction to Venous Thromboembolism

Background/Objectives: Obesity is a major modifiable risk factor for venous thromboembolism (VTE), driven by adipose tissue dysfunction, chronic inflammation, endothelial dysfunction, hypercoagulability, impaired fibrinolysis, immunothrombosis, and venous stasis. Modern incretin-based therapies induce substantial weigh...

Andrea Boccatonda, Alice Brighenti, Alfredo Caturano et al. · Journal of Clinical Medicine · 0 citations

Open access Aug 2026

Clinically recognized sepsis in older adults admitted to medical wards: patient characteristics and hospital outcomes from the REPOSI register.

Older adults admitted to internal medicine wards represent a growing population at high risk of sepsis, characterized by frailty, multimorbidity, functional impairment and reduced physiological reserve. While sepsis outcomes have been extensively studied in intensive care settings, less is known about prognostic determ...

M. Sircana, Alfredo Caturano, Mauro Tettamanti et al. · Internal and Emergency Medic... · 0 citations

Review Open access Sep 2026

Lichen-Derived Bioactive Compounds in Diabetes and Cardiovascular Risk: Experimental Evidence, Mechanisms, and Translational Challenges

Cardiometabolic disorders arise from interconnected metabolic, inflammatory, oxidative, mitochondrial, and vascular abnormalities. Lichens produce structurally diverse secondary metabolites, including depsides, depsidones, dibenzofurans, anthraquinones, and other phenolic compounds, whose experimental activities inters...

Alfredo Torres-Benítez, C. Acierno, Davide Nilo et al. · Biomedicines · 0 citations

Review Open access Sep 2026

Immunometabolism in Obesity-Associated Type 2 Diabetes: Molecular Mechanisms and Emerging Therapeutic Targets

A narrative review synthesises mechanisms and examines how metformin, glucagon-like peptide-1 receptor agonists, sodium–glucose cotransporter 2 inhibitors and inflammasome-directed agents intersect with them in obesity-associated T2D.

C. Acierno, Massimiliano Cavallo, D. D'Ardes et al. · International Journal of Mol... · 0 citations